Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol loading in elective PCI
NCT00938522Phase 4Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jul 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary artery disease (CAD) comparing Cilostazol loading with Placebo (2 arms). Primary endpoint: Major adverse cardiac and cerebrovascular events at 3 months. Status: unknown.
02
Drugs
cilostazol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00938522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00938522.